Needleman program seeks proposals
The Needleman Program for Innovation and Commercialization provides funding for researchers developing promising new therapeutics, helping them progress to early-stage clinical trials. A second call for proposals is now open.
The submission deadline is March 15. Learn more here (WUSTL Box login required).
Curiel, Janetka named fellows of National Academy of Inventors
David T. Curiel, MD, PhD, and James W. Janetka, PhD – both of Washington University School of Medicine in St. Louis – have been named fellows of the National Academy of Inventors (NAI). The recognition represents the highest professional distinction accorded solely to academic inventors.
Academy honors six university faculty
Six Washington University in St. Louis faculty members and one alumnus are being honored by the Academy of Science – St. Louis for their outstanding contributions to the field. They will be recognized at an awards dinner Sept. 20 at the Missouri Botanical Garden.
Yang elected senior member of National Academy of Inventors
Lan Yang, the Edwin H. & Florence G. Skinner Professor in the Preston M. Green Department of Electrical & Systems Engineering at the McKelvey School of Engineering at Washington University in St. Louis, has been elected a senior member of the National Academy of Inventors (NAI).
Genin, Guilak named to National Academy of Inventors
The National Academy of Inventors (NAI) has elected two Washington University in St. Louis faculty members to its 2022 cohort of fellows: Guy Genin, the Harold and Kathleen Faught Professor of Mechanical Engineering at the McKelvey School of Engineering, and Farshid Guilak, the Mildred B. Simon Research Professor of Orthopaedic Surgery at the School of Medicine.
University again named to top 100 patent list
Washington University in St. Louis is included in a report released Sept. 7 by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association, ranking it among the top 100 universities worldwide granted U.S. patents in 2020.
DiPersio receives awards recognizing contributions to cancer care, research
John F. DiPersio, MD, PhD is a leader in developing novel therapies for leukemia and in understanding how such therapies work.
Lishko named BJC Investigator
Polina V. Lishko co-founded the startup company YourChoice Therapeutics. While she has since stepped away from the company, YourChoice Therapeutics continues to build on her research to develop temporary, nonhormonal contraceptives.